Marathon Trading Investment Management’s Eli Lilly LLY Stock Holding History

Marathon Trading Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Sell	290 -210	-42%	-$215K	0.01%	162
2026 Q1	$460K	Buy	+500	New	+$507K	0.01%	130
2025 Q2	–	Sell	-300	Closed	-$248K	–	336
2025 Q1	$248K	Sell	300 -500	-63%	-$416K	0.03%	213
2024 Q4	$618K	Buy	+800	New	+$662K	0.03%	152
2014 Q3	–	Sell	-4,400	Closed	-$274K	–	333
2014 Q2	$274K	Buy	+4,400	New	+$263K	0.01%	264

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marathon Trading Investment Management's LLY Position: Q2 2026 in Review

Marathon Trading Investment Management reduced its Eli Lilly (LLY) stake by 42% in Q2 2026, selling an estimated $215K and leaving 290 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #162.

Marathon Trading Investment Management first reported a position in LLY in Q2 2014 and has held it in 5 quarters since. The position peaked at $618K in Q4 2024. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Marathon Trading Investment Management held 290 shares of Eli Lilly worth $348K as of Q2 2026.
Marathon Trading Investment Management sold 210 Eli Lilly shares in Q2 2026, an estimated $215K.
Eli Lilly made up 0.01% of Marathon Trading Investment Management's portfolio in Q2 2026, its #162 holding.
Marathon Trading Investment Management first reported a position in Eli Lilly in Q2 2014 and has held it in 5 quarters since.
Marathon Trading Investment Management's Eli Lilly position peaked at $618K in Q4 2024.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marathon Trading Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.